Focus:
Analysis
-
![ConcePTION: tackling the unknowns of medication in pregnancy]()
ConcePTION: tackling the unknowns of medication in pregnancy
The gaps in knowledge when it comes to the use of medication during pregnancy and breastfeeding are vast. A pan-European body called ConcePTION has been awarded a five-year grant by...
-
![Queen’s Speech 2019: UK seeks to strengthen NHS and life sciences]()
Queen’s Speech 2019: UK seeks to strengthen NHS and life sciences
In the first Queen’s Speech since the UK began negotiating Brexit with the EU, the UK Government laid out, among other things, its commitments to supporting and strengthening the life...
-
![How do cancer cells communicate and can it help us catch them?]()
How do cancer cells communicate and can it help us catch them?
Researchers have uncovered that cancer cells communicate over much greater distances than previously expected, opening up more possibilities for detection. We spoke to the researchers to get the inside track...
-
![From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes]()
From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes
Almost 15 years after the approval of the first GLP-1 agonist, the US FDA has approved the first oral version of this treatment approach for type 2 diabetes. What are...
-
![Understanding drug-resistant TB]()
Understanding drug-resistant TB
Drug-resistant tuberculosis causes one third of all antimicrobial resistance related deaths, presenting an enormous challenge. The threat is growing and has the potential to spiral out of control as drugs...
-
![CBD: the myth, the magic and the real deal drugs]()
CBD: the myth, the magic and the real deal drugs
The use of cannabidiol, or CBD, has surged in popularity, but is it comparable to other more established drugs for similar indications? Abi Millar takes a look at the pharmaceutical...
-
![The drugs fighting memory loss]()
The drugs fighting memory loss
Researchers in Toronto have developed an experimental drug that appears to renew the underlying brain impairments causing memory loss, fuelling hopes that a treatment for cognitive decline linked to depression...
-
![Medical cannabis in the UK: how has the roll out gone so far?]()
Medical cannabis in the UK: how has the roll out gone so far?
Medical cannabis was legalised in the UK late last year, but patient access remains a problem, with only a handful of cannabis-based medical products prescribed so far. Abi Millar asks...
-
![September’s top news stories]()
September’s top news stories
Gavi Vaccine Alliance seeks $7. 4bn to immunise 300 million people and Researchers find new drug with promise for malaria treatment. Pharmaceutical-technology.com wraps up key headlines from September 2019.
-
![Are we nearing the end of animal testing in pharma?]()
Are we nearing the end of animal testing in pharma?
Responding to lobbying and mounting evidence that animal testing is an insufficient predictor of drug safety in humans, research institutes and pharma companies have begun to move away from pre-clinical...
